Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

US FDA reviewing concerns over Logan Paul's PRIME energy drink

Published 07/12/2023, 07:12 PM
Updated 07/13/2023, 11:01 AM
© Reuters. FILE PHOTO: Youtube personalities Logan Paul of the U.S. and rapper KSI of Britain, meet fans during a Prime soft drink promotional event in Copenhagen, Denmark, June 27, 2023. Ritzau Scanpix/Ida Marie Odgaard via REUTERS/File Photo

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it is reviewing concerns raised by Senate Majority Leader Chuck Schumer against a popular influencer-created energy drink.

Schumer said earlier this month that PRIME, a beverage brand started last year by YouTube stars Logan Paul and KSI, should be investigated due to the high caffeine content in the energy drink, adding that it was also being marketed to children.

Prime Energy contains 200 milligrams of caffeine per 12 ounces, equal to six cans of Coca-Cola (NYSE:KO) or nearly two Red Bulls.

Canadian health officials told Reuters on Wednesday the energy drink should not be sold in Canada as the product exceeds the acceptable caffeine limits.

According to Canadian regulations, energy drinks must not contain more than 180 mg of caffeine in a single-serving container and require cautionary statements to protect sensitive subpopulations, including children.

The Canada health agency is aware that some stores in Canada may be selling Prime Energy without approval and it is actively working to address this issue, a spokesperson said.

The company said in an emailed statement it complied with all FDA guidelines before hitting the market and states clearly on packaging, as well as in marketing materials, that it is an energy drink and is not made for anyone under the age of 18.

The company also sells a non-caffeinated hydration drink. Schumer previously said the packaging and marketing of the two drinks were so similar that parents were unknowingly buying the highly caffeinated energy drinks for their children.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The U.S. health regulator said it will respond to Schumer directly regarding his concerns.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.